共 11 条
[1]
2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer[J]. Ming Gao,Minghua Ge,Qinghai Ji,Ruochuan Cheng,Hankui Lu,Haixia Guan,Wei Cui,Li Gao,Zairong Gao,Lin Guo,Zhuming Guo,Tao Huang,Xiaoming Huang,Yansong Lin,Qinjiang Liu,Xin Ni,Jianwu Qin,Li Ren,Zhongyan Shan,Hui Sun,Xudong Wang,Zhengang Xu,Yang Yu,Bin Zhang,Daiwei Zhao,Ying Zheng,Jingqiang Zhu,Xiangqian Zheng.Cancer Biology & Medicine. 2018(04)
[2]
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?[J] . Sophie Leboulleux,R Michael Tuttle,Furio Pacini,Martin Schlumberger.The Lancet Diabetes & Endocrinology . 2016 (11)
[7]
Papillary Thyroid Microcarcinoma: Extrathyroidal Extension, Lymph Node Metastases, and Risk Factors for Recurrence in a High Prevalence of Goiter Area[J] . Celestino P. Lombardi,Rocco Bellantone,Carmela De Crea,Nunzia C. Paladino,Guido Fadda,Massimo Salvatori,Marco Raffaelli.World Journal of Surgery . 2010 (6)
[9]
Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma[J] . Nimmi Arora,Harma K. Turbendian,Theresa Scognamiglio,Patrick L. Wagner,Stanley J. Goldsmith,Rasa Zarnegar,Thomas J. Fahey.Surgery . 2008 (6)
[10]
Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients[J] . M.R. Pelizzo,I.M. Boschin,A. Toniato,A. Piotto,P. Bernante,C. Pagetta,L. Rampin,D. Rubello.European Journal of Surgical Oncology . 2006 (10)